A Call to Reduce the Use of Bridging Anticoagulation

Adam J. Rose, Arthur L. Allen, Tracy Minichello

פרסום מחקרי: פרסום בכתב עתסקירהביקורת עמיתים

תקציר

Because of the recent publication of several important studies, there has been a major change in how we think about perioperative management of anticoagulation. Because of these changes, existing consensus guidelines are suddenly out of date and can no longer be used as is, particularly the 2012 American College of Chest Physicians Antithrombotic Guidelines, version 9. We estimate that well over 90% of patients receiving warfarin therapy should not receive bridging anticoagulation during periprocedural interruptions of therapy, except under unusual circumstances and with appropriate justification. Accumulating evidence also suggests that bridging is not indicated among patients receiving direct-Acting oral anticoagulant therapy. The large number of patients potentially affected represents an important safety concern and requires an immediate change in practice.

שפה מקוריתאנגלית אמריקאית
עמודים (מ-עד)64-67
מספר עמודים4
כתב עתCirculation: Cardiovascular Quality and Outcomes
כרך9
מספר גיליון1
מזהי עצם דיגיטלי (DOIs)
סטטוס פרסוםפורסם - 1 ינו׳ 2016
פורסם באופן חיצוניכן

ASJC Scopus subject areas

  • ???subjectarea.asjc.2700.2705???

טביעת אצבע

להלן מוצגים תחומי המחקר של הפרסום 'A Call to Reduce the Use of Bridging Anticoagulation'. יחד הם יוצרים טביעת אצבע ייחודית.

פורמט ציטוט ביבליוגרפי